Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Dalli Asks EU Court to Overturn Resignation Over Fraud Probe

Don't Miss Out —
Follow us on:

Feb. 18 (Bloomberg) -- John Dalli, who stepped down as the European Union’s health commissioner in October, asked an EU court to overturn his resignation in the wake of a fraud investigation.

Dalli is asking the EU’s General Court to annul an Oct. 16 “termination of office,” according to a court filing published this week. The action wasn’t a valid resignation and didn’t allow him to defend himself against allegations that he was aware of attempts by a Maltese entrepreneur to sell access to him in a possible attempt to influence the bloc’s tobacco policy, according to the filing.

Dalli said last year that his resignation was “explicitly demanded” by European Commission President Jose Barroso and that he was refused access to a report by the EU’s anti-fraud office, OLAF. It was “politically untenable” for Dalli to remain in his post after the report uncovered circumstantial evidence that he knew of the effort to sell access to him, an EU spokesman said in October.

His resignation was the first by an EU commissioner over corruption allegations since the entire commission resigned in 1999 after several members were accused of financial wrongdoing. Dalli was succeeded by Tonio Borg as Malta’s representative at the European Commission.

The case is: T-562/12 Dalli v Commission.

To contact the reporter on this story: Aoife White in Brussels at awhite62@bloomberg.net.

To contact the editor responsible for this story: Anthony Aarons at aaarons@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.